These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
608 related articles for article (PubMed ID: 11798803)
1. [Construction of a hepatoma-targeting vector of adeno-associated virus containing human alpha-fetoprotein promoter and wild p53 gene in gene therapy of liver cancer]. Cheng J; Leng X; Peng J Zhonghua Yi Xue Za Zhi; 2000 Jun; 80(6):461-3. PubMed ID: 11798803 [TBL] [Abstract][Full Text] [Related]
2. [Construction, packaging and titration of recombinant adeno-associated virus vectors contaning antitumor genes]. Zhang Y; Leng X; Peng J; He X; Lu J; Weng S; Wang S; Du J Zhonghua Yi Xue Za Zhi; 2002 Apr; 82(8):564-7. PubMed ID: 12133507 [TBL] [Abstract][Full Text] [Related]
3. Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter. Ido A; Uto H; Moriuchi A; Nagata K; Onaga Y; Onaga M; Hori T; Hirono S; Hayashi K; Tamaoki T; Tsubouchi H Cancer Res; 2001 Apr; 61(7):3016-21. PubMed ID: 11306481 [TBL] [Abstract][Full Text] [Related]
4. Recombinant adeno-associated virus derived vectors (rAAV2) efficiently transduce ovarian and hepatocellular carcinoma cells--implications for cancer gene therapy. MaĆecki M; Swoboda P; Pachecka J Acta Pol Pharm; 2009; 66(1):93-9. PubMed ID: 19226976 [TBL] [Abstract][Full Text] [Related]
5. [Construction and study of replication-defective adenovirus targeting hepatocarcinoma]. Xu DY; Du ZY; Wang Y; Chen HH; Xu YJ; Lu YL Ai Zheng; 2006 Jul; 25(7):798-804. PubMed ID: 16831267 [TBL] [Abstract][Full Text] [Related]
6. Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene. Kanai F; Shiratori Y; Yoshida Y; Wakimoto H; Hamada H; Kanegae Y; Saito I; Nakabayashi H; Tamaoki T; Tanaka T; Lan KH; Kato N; Shiina S; Omata M Hepatology; 1996 Jun; 23(6):1359-68. PubMed ID: 8675152 [TBL] [Abstract][Full Text] [Related]
7. Utilization of variant-type of human alpha-fetoprotein promoter in gene therapy targeting for hepatocellular carcinoma. Ishikawa H; Nakata K; Mawatari F; Ueki T; Tsuruta S; Ido A; Nakao K; Kato Y; Ishii N; Eguchi K Gene Ther; 1999 Apr; 6(4):465-70. PubMed ID: 10476206 [TBL] [Abstract][Full Text] [Related]
8. [Impact of AFP promoter on the expressions of GFP in tumor cells]. Mao CQ; Huang CZ; Yang SD; Zhao M; Fan YX; Xu F; Du F Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Oct; 23(5):495-8. PubMed ID: 12905870 [TBL] [Abstract][Full Text] [Related]
9. Targeting gene therapy for hepatocarcinoma cells with the E. coli purine nucleoside phosphorylase suicide gene system directed by a chimeric alpha-fetoprotein promoter. Cai X; Zhou J; Chang Y; Sun X; Li P; Lin J Cancer Lett; 2008 Jun; 264(1):71-82. PubMed ID: 18407409 [TBL] [Abstract][Full Text] [Related]
10. [Construction of recombinant adeno-associated virus vector co-expressing hVEGF165 and hBMP-7 genes]. Huang X; Shi Z; Wang K; Dang X; Yang P; Yu P Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Jul; 22(7):807-13. PubMed ID: 18681280 [TBL] [Abstract][Full Text] [Related]
11. Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter. Ido A; Nakata K; Kato Y; Nakao K; Murata K; Fujita M; Ishii N; Tamaoki T; Shiku H; Nagataki S Cancer Res; 1995 Jul; 55(14):3105-9. PubMed ID: 7541712 [TBL] [Abstract][Full Text] [Related]
12. [Establishment of AFP promoter operated murine IL-1beta recombinant vector and its expression in H22 cells]. Li QC; Liang SJ; Wang XJ; Liu YY; Wang HQ; Zhang SH Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Jul; 25(7):603-5. PubMed ID: 19737477 [TBL] [Abstract][Full Text] [Related]
13. [Killing effect of PNP/MeP-dR suicide gene system driven by an AFP promoter AF0.3 on AFP-positive hepatoma cells]. Cai XK; Zhou JL; Zhou HJ; Zhang L; Wu JH; Lin JS Ai Zheng; 2006 Nov; 25(11):1334-9. PubMed ID: 17094897 [TBL] [Abstract][Full Text] [Related]
14. [Recombinant plasmid pEGFP-AFP-TK delivered by nano-magnetic fluids targeting killed AFP positive HepG2 cells in vitro]. Luo Y; Zhang YD; Peng J; Yan HX; Xue D; Wu K; Zhou L; Hang SW; Zhao JF Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 May; 25(5):437-9. PubMed ID: 19426602 [TBL] [Abstract][Full Text] [Related]
15. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap. Conway JE; Rhys CM; Zolotukhin I; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ Gene Ther; 1999 Jun; 6(6):986-93. PubMed ID: 10455400 [TBL] [Abstract][Full Text] [Related]
16. Targeted IL-24 gene therapy inhibits cancer recurrence after liver tumor resection by inducing tumor cell apoptosis in nude mice. Yang YJ; Chen DZ; Li LX; Sheng QS; Jin ZK; Zhao DF Hepatobiliary Pancreat Dis Int; 2009 Apr; 8(2):174-8. PubMed ID: 19357032 [TBL] [Abstract][Full Text] [Related]
17. Transactivation of human alpha-fetoprotein gene by X-gene product of hepatitis B virus in human hepatoma cells. Arima T; Nakao K; Nakata K; Ishikawa H; Ichikawa T; Hamasaki K; Ishii N; Eguchi K Int J Mol Med; 2002 Apr; 9(4):397-400. PubMed ID: 11891535 [TBL] [Abstract][Full Text] [Related]
18. [Experimental studies in vitro on the alpha-fetoprotein-specific promoter mediated target gene therapy of hepatocellular carcinoma]. Quan S; Pan G; Lu C; Liu D; Fang F Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Apr; 21(2):111-7. PubMed ID: 12569665 [TBL] [Abstract][Full Text] [Related]
19. Retrovirus-mediated gene therapy for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by human alpha-fetoprotein enhancer directly linked to its promoter. Mawatari F; Tsuruta S; Ido A; Ueki T; Nakao K; Kato Y; Tamaoki T; Ishii N; Nakata K Cancer Gene Ther; 1998; 5(5):301-6. PubMed ID: 9824049 [TBL] [Abstract][Full Text] [Related]
20. [Construction of a plasmid vector of fused protein genes driven by human insulin-like growth factor II P3 promoter]. Zhou HK; Yang DH; Tang SH; Huang W; Lu XH Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):106-10. PubMed ID: 16620715 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]